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Abstract. The researches were made during February – June 2011 within the 
Microbiology Laboratory of the Faculty of Veterinary Medicine Cluj-Napoca. A total number 
of 16 Candida spp. strains isolated from both healthy and diseased animals from different 
species and humans and 2 ATCC strains, were tested regarding the sensitivity to antimycotics 
such as: Nystatin, Fluorocytosine, Miconazole, Itraconazole, Amphotericin B and 
Ketoconazole. For the isolated strains from parrot faeces, Miconazole and Amphotericin B 
were the most efficient; for dog otitis - Miconazole; for mastitis cow milk - Nystatin; for 
human tonsillitis – Amphotericin B; for ATCC 90028 – Miconazole and for ATCC 10231 – 
Amphotericin B. Regarding overall sensibility Miconazole was the most efficient antimycotic 
for all the strains tested in this study. 
 
Key words: Candida spp., sensitivity, antimycotics, animals. 
 
INTRODUCTION 
 
Fungi are eukaryotic organisms with approximately 300 000 different species. Of 
these, about 200 are potential parasites, with only a few of these affecting animals (1). Fungal 
diseases of mammals, mycoses, range from the common mild cutaneous or subcutaneous skin 
infections, to the potentially lethal acute or chronic infection of deep tissues that are typically 
caused by Candida species. Of the Candida species affecting animals, Candida albicans is by 
far the most common. Candida albicans belongs to the class Ascomycetes and the family 
Saccharomycetaceae. This yeast can live as harmless commensal in many different body 
locations, and is carried in almost half of the population (5). However, in response to a change 
in the host environment, Candida can convert from a benign commensal into a disease-
causing pathogen, causing infections in the oral, gastrointestinal, skin and genital tracts (1,). 
Yeast resistance to antimycotics is a major problem of the latest decades, candida being 
the most important pathogenic potential yeast. Synthetic antifungal drugs are used to prevent 
and treat fungal skin infections, especially in immunocompromised patients such as those 
with AIDS or those on chemotherapy(3).  
Ketoconazole is very lipophilic, which leads to accumulation in fatty tissues. The less 
toxic and more effective triazole compounds fluconazole and itraconazole have largely 
replaced ketoconazole for internal use. As an antifungal, ketoconazole is structurally similar 
to imidazole and interferes with the fungal synthesis of ergosterol, a constituent of fungal cell 
membranes, as well as certain enzymes. As with all azole antifungal agents, ketoconazole 
works principally by inhibiting the enzyme cytochrome P450 14-alpha-demethylase 
(P45014DM). This enzyme participates in the sterol biosynthesis pathway that leads from 
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lanosterol to ergosterol. Lower doses of fluconazole and itraconazole are required to kill fungi 
compared to ketoconazole, as they have been found to have a greater affinity for fungal cell 
membranes(2). 
The researches aimed to evaluate “in vitro” the efficiency of different antimycotics on 
18 Candida spp. strains isolated from both healthy and diseased animals. 
 
MATERIALS AND METHODS 
 
 The investigations took place during February – June 2011 within the Microbiology 
Laboratory of the Faculty of Veterinary Medicine Cluj-Napoca. A total number of 18 
Candida spp. strains were isolated from both healthy and diseased animals, as well as samples 
collected from human tonsillitis. The samples collected from diseased animals and their type 
of lesions were represented by: mastitis cow milk, dogs suffering from otitis, cats and dogs 
suffering from tonsillitis and parrot faeces. Two control Candida albicans strains were also 
used within the study (ATCC 90028 and ATCC 10231).  
72 hours culture of the strains taken into study cultivated on glucose agar and 
incubated at 37°C was suspended in saline to a density of 0,5 on McFarland scale (150 x 10
6
 
CFU/ml). Petri dishes of 9 cm diameter containing glucose agar were flooded with the 
suspension for each strain and the excess removed. After drying the agar surface, standardized 
antimycotics were placed by the antibiogram model. They were represented by Nystatin 
(NYSTA), Fluorocytosin (FLU1), Miconazole (MICOZ), Itraconazole (ITC50), Amphotericin 
(AMB20) and Ketoconazole (Kt). The results were interpreted determining the inhibition area 
around each micro disc after 48-72 h incubation at 37°C. 
 
RESULTS AND DISCUSSIONS 
 
The results registered for the total number of 18 tested Candida spp. strains are 
presented in table 1. 
Tab. 1. 
 Results (mm inhibition area diameter) of the sensibility to antimycotics for the tested strains 
Antimycotic 
/Candida strain 
Nystatin Fluorocytosine Miconazole Itraconazole Amphotericin Ketoconazole 
1-201 20 R 13 R 17 R 
28-09 17 R R 13 12 R 
L.A. 19 R 20 R 18 R 
L.M. R R R R 18 R 
201/2009 19 R 12 R 18 R 
3-197 R R 23 R R R 
34-9 17 R 15 R 17 R 
31-13 18 R 20 14 18 R 
20/2011 18 R 20 R 17 24 
33-22 15 R 18 17 18 25 
EZV 18 R 19 R 16 R 
22-13a 17 R 16 14 18 R 
88/2011 R R 16 R 14 R 
MAM 18 R 16 R 17 R 
24-9 R R 22 15 R R 
33-18a 13 R 17 R 16 12 
90028 R R 32 R R R 
10231 18 R 11 R 20 R 
R - resistant 
 270 
The best sensitivity of the tested strains is registered for Miconazole, followed by 
Amphotericin, Nystatin and Itraconazole, while the least efficient antimycotic was 
Fluorocytosine followed by Ketoconazole. 
Regarding averages of the inhibition area diameter (in mm) for the strains taken into 
study, for Miconazole the value is 16.11, for Amphotericin 14.11, for Nystatin 12.61, in case 
of Itraconazole 4.05, 3.38 for Ketoconazole and o for Fluorocytosine. Chart 1 clearly express 
the values of average inhibition diameters. 
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Chart 1. Average of the inhibition area diameter (in mm) for the strains taken into study 
 
 Regarding the sensitivity of the strains isolated from parrot faeces, Miconazole and 
Amphotericin B were the most efficient; for dog otitis - Miconazole; for mastitis cow milk - 
Nystatin; for human tonsillitis – Amphotericin B; for ATCC 90028 – Miconazole and for 
ATCC 10231 – Amphotericin B. 
 The following images are presenting the sensitivity area diameter for a strain collected 
from mastitis cow milk (left) and parrot faeces (right). 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Fig. 1. Sensitivity to antimycotics of a strain       Fig. 2. Sensitivity to antimycotics of a strain 
isolated from mastitis cow milk         isolated from parrot faeces 
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CONCLUSIONS 
 
 The global sensitivity of Candida spp. strains tested is satisfactory observing that for each 
strain at least one antimycotic can be recommended for the therapy. 
 Miconazole was the most efficient antimycotic considering the average of the inhibition 
area diameters and the sensitivity of each tested strain. 
 Fluorocytozin is an antimycotic drug that in case of the strains tested within this study had 
no efficiency. 
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